 
    Homsun Capital is an investment firm.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Nov 11, 2020
                      
                            Asieris Pharmaceuticals | Series D | ¥700M | Biotechnology | — | 
| 
                      Mar 7, 2017
                      
                            ChoiPharm | Angel | ¥3M | Biotechnology | — | 
| 
                      Feb 22, 2017
                      
                           | Angel | ¥3M | Health Care | — | 
| 
                      Jun 24, 2016
                      
                            Tianzhi Hulian | Series B | ¥20M | Information Technology | — | 
| 
                      Oct 28, 2011
                      
                            L'AVION | Series A | ¥10M | Health Care | Yes | 
Homsun Capital has had 2 exits. Homsun Capital most notable exits include Asieris Pharmaceuticals , Tianzhi Hulian
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 7, 2022 | Asieris Pharmaceuticals | IPO | Biotechnology | Detail | 
| May 2, 2017 | Tianzhi Hulian | IPO | Information Technology | Detail |